Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002132 · ClinicalTrials.gov registry record · NA

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

A NA study of HIV Infections and Candidiasis, Esophageal, sponsored by Janssen Pharmaceuticals.

Completed
Registry status
NA
Development phase
18
Study locations

NCT00002132: Completed NA study of HIV Infections and Candidiasis, Esophageal, sponsored by Janssen Pharmaceuticals.

NCT00002132 is a NA study of HIV Infections and Candidiasis, Esophageal that has completed, run by Janssen Pharmaceuticals. The trial reports 18 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002132, a NA study of HIV Infections and Candidiasis, Esophageal, has completed, sponsored by Janssen Pharmaceuticals.

COMPLETED
Registry status
NA
Development phase
18
Study locations

Study Summary

To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.

Conditions Studied

HIV Infections Candidiasis, Esophageal

Interventions

  • DRUG Fluconazole
  • DRUG Itraconazole

Study Locations (18)

New York

  • Erie County Med Ctr - Buffalo
  • Dr Douglas Dieterich - New York
  • Montefiore Med Ctr - The Bronx

California

  • Los Angeles County - USC Med Ctr - Los Angeles
  • UCSD Med Ctr - San Diego

Missouri

  • Univ of Missouri at Kansas City School of Medicine - Kansas City
  • Infectious Diseases Association / Research Med Ctr - Kansas City

North Carolina

  • Univ of North Carolina - Chapel Hill
  • Bowman Gray School of Medicine - Winston-Salem

Texas

  • Austin Infectious Disease Consultants - Austin
  • Houston Veterans Administration Med Ctr - Houston

Arizona

  • Dr Eskild A Petersen - Tucson

District of Columbia

  • George Washington Univ Med Ctr - Washington D.C.

Georgia

  • Emory Univ School of Medicine - Atlanta

Trial Details

FieldValue
Phase NA
Janssen Pharmaceuticals

1 total trials

What the finished NCT00002132 record still lists

NCT00002132 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Fluconazole is the first listed.

NCT00002132 lists 18 locations in 12 states (New York, California, Missouri).

Frequently Asked Questions

What is clinical trial NCT00002132 about?

NCT00002132 is a clinical study titled "Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.". To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.

What is the current status of trial NCT00002132?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002132 study?

This clinical trial studies the following conditions: HIV Infections, Candidiasis, Esophageal.

What interventions are being tested in trial NCT00002132?

The interventions under investigation include: Fluconazole (DRUG), Itraconazole (DRUG).

Who is sponsoring clinical trial NCT00002132?

This trial is sponsored by Janssen Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002132 being conducted?

This trial has 18 study locations across Arizona, California, District of Columbia, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00002132, the US trial registry maintained by the National Library of Medicine. NCT00002132 (unsized enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.